Pharma Co. Impel's Ch. 11 Liquidation Plan Approved
By Ben Zigterman · April 1, 2024, 5:07 PM EDT
Migraine-drug maker Impel Pharmaceuticals received confirmation of its Chapter 11 liquidation plan on Monday after selling its assets and making changes to the plan's exculpation provisions in response to a U.S....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login